Literature DB >> 12556671

Therapeutic lifestyle changes for hypertension and cardiovascular risk reduction.

Karol Watson1, Kenneth Jamerson.   

Abstract

Elevated blood pressure is the most common chronic illness in the United States, affecting more than 50 million people. Hypertension is an even greater problem in the African American community. Traditionally, management of hypertension and cardiovascular risk reduction has focused on drug therapy; however, several studies have shown the benefits of therapeutic lifestyle changes for blood pressure lowering and cardiovascular risk reduction. Therapeutic lifestyle changes to reduce blood pressure have enormous potential as a means for preventing and controlling hypertension and thereby reducing the risk of coronary heart disease. Although the reductions in blood pressure are relatively modest with these approaches, they could potentially have a beneficial impact on overall cardiovascular morbidity and mortality when applied to the whole population. Because of their high prevalence of certain cardiovascular risk factors (e.g., obesity, diabetes mellitus) and greater salt sensitivity, therapeutic lifestyle changes have particular relevance for African Americans. Copyright 2003 Le Jacq Communications, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12556671      PMCID: PMC8101831          DOI: 10.1111/j.1524-6175.2003.02179.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Very-low fat diets.

Authors:  D Ornish
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 3.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

4.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

5.  Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial.

Authors:  E Obarzanek; F M Sacks; W M Vollmer; G A Bray; E R Miller; P H Lin; N M Karanja; M M Most-Windhauser; T J Moore; J F Swain; C W Bales; M A Proschan
Journal:  Am J Clin Nutr       Date:  2001-07       Impact factor: 7.045

6.  Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

Authors:  V J Stevens; E Obarzanek; N R Cook; I M Lee; L J Appel; D Smith West; N C Milas; M Mattfeldt-Beman; L Belden; C Bragg; M Millstone; J Raczynski; A Brewer; B Singh; J Cohen
Journal:  Ann Intern Med       Date:  2001-01-02       Impact factor: 25.391

Review 7.  Nonpharmacologic therapies that reduce blood pressure: a fresh perspective.

Authors:  L J Appel
Journal:  Clin Cardiol       Date:  1999-07       Impact factor: 2.882

8.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

Authors: 
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

9.  Smoking and myocardial infarction.

Authors:  C Wilhelmsson; J A Vedin; D Elmfeldt; G Tibblin; L Wilhelmsen
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

10.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.

Authors:  L J Appel; T J Moore; E Obarzanek; W M Vollmer; L P Svetkey; F M Sacks; G A Bray; T M Vogt; J A Cutler; M M Windhauser; P H Lin; N Karanja
Journal:  N Engl J Med       Date:  1997-04-17       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.